One of the life-saving medicines for leukemia people in the process of hematopoietic stem cell transplantation - "Bai Shufei" is out of stock on the national drug market for more than 3 months. Many hospitals in Henan have been in short supply since August, and many patients are faced with an inoperable condition. . It is understood that such drugs are produced in only one enterprise in the world. â–¡ Oriental News reporter Dong Caihong
Can't wait for "life-saving drugs" surgery can only postpone
“I want to cure the disease early and return to school.†Xiao Zhao (a pseudonym) at the age of 21 is a sophomore student from a college in Zhengzhou. In school, love, laugh, love, jump, is simply everyone's pistachio.
Six months ago, God of Fate made a joke with Xiao Zhao. During that time, Koo often looked pale, sweated, and often had a high fever. There was no more vivacious ability to jump before. She even joked herself "how suddenly became Lin sister." After going to the hospital for an examination, the bad news came: Xiaozhao had acute leukemia.
Leukemia is a malignant disease of the hematopoietic system. The best treatment is bone marrow transplantation. Fortunately, Xiao Zhaohe's younger brother had a successful bone marrow formup and he was able to arrange surgical treatment in the near future. However, it is worrying that at this time, Xiaozhao's surgery fell into the embarrassing situation of "waiting for drugs" due to lack of medicine.
Sun Hui, director of the Department of Hematology at the First Affiliated Hospital of Zhengzhou University, introduced that Bai Shufei is an essential drug in bone marrow transplantation. This drug is currently very scarce, and there is only one hospital inventory left. "And according to Xiao Zhao's weight, she needs at least 12 to 13 Bai Shufei injections."
Due to the lack of necessary medicines for surgery, Xiao Zhao's surgery can only be postponed.
Not only is Zhengzhou out of stock, but patients all over the country are seeking drugs.
Yesterday, the Oriental News reporter visited Henan Provincial People's Hospital, Henan Provincial Tumor Hospital, and the Third People's Hospital of Zhengzhou City, all of whom faced an emergency situation of “whiteness is not critical and affects patients’ surgeryâ€.
Zhang Yin, director of the Department of Hematology at the Provincial People's Hospital, said that since August this year, Bai Shufei’s supply has been in short supply. Nowadays, intravenous injections of Bai Shufei have almost no inventory, and they can only be replaced with oral Baishufei during surgery. However, Bai Shufei of the oral class also began to face shortages. This has forced many patients with leukemia to be forced to search for drugs. If patients cannot find drugs, they can only be forced to choose other treatments with greater side effects. If radiotherapy is not suitable for everyone, it can only replace part of it.
It is understood that there have been illegal imitations of the Bai Shu Fei generic drugs in Japan and India. Experts recommend that patients do not purchase because generic drugs have not been tested by the state and quality and efficacy are not guaranteed. At the same time, Bai Sufei's posts are available on Weibo and forums.
This situation not only exists in Zhengzhou, in Beijing, Shanghai and other places, everywhere are looking forward to looking for patients with Bai Shufei.
Yesterday afternoon, on the Weibo, the Oriental Daily News reporter randomly entered the words "white Shu Fei" with 348 search results. Most of the contents of the patient's family are looking for Bai Shufei everywhere.
A @ baby Ankang 515's friends made a micro-Bo said that Xue Bao’s father went to the hospital today to see if there was one or two remaining Bai Shufei in the hospital. Amitabha, Buddha bless! Really he was hit by a...
@ Beijing help SOS: urgent! Who has purchased Bai Shufei's channel? Children with leukemia Xiao Tengrui will enter the transplant warehouse at the beginning of next month. Unexpectedly, the medicine Bai Shufei who is preparing to warehousing will be out of stock. The doctor will let the patient prepare for himself. This medicine is not good to buy. Who will buy Bai Shufei's channels?
Only one company in the world produces
What role does Bai Shufei play in surgery? Why frequent out of stock?
According to Zhang Yin, in recent years, the incidence of leukemia is getting higher and higher. The most effective way to treat this disease is bone marrow transplantation. Bai Shufei's role in bone marrow transplantation is that many other drugs cannot substitute. It is understood that this medicine is produced in the United States, and there is only one manufacturing enterprise in the world, and China is the only one that can be imported by Qilin Pengeng (China) Biological Pharmaceutical Co., Ltd.
In an interview with the media, Bai Tianfei, head of Bai Shufei's global pharmaceutical company, Japan Otsuka Pharmaceutical Co., Ltd., said that Bai Shufei was originally manufactured at a BVL manufacturing facility in the United States. However, due to repeated problems in the BVL production base, two years ago they had started preparations for another backup production base - DSM production base.
According to relevant regulations, the change of pharmaceutical production base requires the re-approval of the Food and Drug Administration of each country before it can enter the market.
Beitian will charge that in August this year, they had submitted their applications to the relevant regulatory authorities in China and are still under review. “Before it was approved, the original plan was to continue to provide China with Bai Shufei, which was made from the former production site BVL, but the production line at the BVL production site had recently experienced problems, which led to a global supply shortage.â€
Will build a shortage of drug reserves
Why the drug depends on imports, the relevant person in charge of the State Food and Drug Administration said that Chinese pharmaceutical companies actually have the ability to produce this drug, but because of the large investment in this drug, the profit is low, resulting in the current situation .
It is understood that in September this year, there was a shortage of protamine in cardiac surgery, and it was less than two months old. Bai Shufei, a key drug in bone marrow transplantation, was in short supply again. In this case, yesterday, the relevant person in charge of the Provincial Food and Drug Administration revealed that in recent days, the Ministry of Health and the Ministry of Industry and Information Technology issued notices on the shortage of infectious drug and first-aid-type drug supply guarantees, and required local governments to make short-term treatment of infectious diseases and emergency drugs. The supply of essential drugs is guaranteed. Therefore, the next step is to establish a system for short-term drug shortages as soon as possible.
Wu Yuewen, chief physician of Department of Hematology at the Henan Provincial Tumor Hospital, who has been paying attention to the matter, said that the latest news she received is that the Baishufei production line has resumed production and is expected to be available to various hospitals soon.
Can't wait for "life-saving drugs" surgery can only postpone
“I want to cure the disease early and return to school.†Xiao Zhao (a pseudonym) at the age of 21 is a sophomore student from a college in Zhengzhou. In school, love, laugh, love, jump, is simply everyone's pistachio.
Six months ago, God of Fate made a joke with Xiao Zhao. During that time, Koo often looked pale, sweated, and often had a high fever. There was no more vivacious ability to jump before. She even joked herself "how suddenly became Lin sister." After going to the hospital for an examination, the bad news came: Xiaozhao had acute leukemia.
Leukemia is a malignant disease of the hematopoietic system. The best treatment is bone marrow transplantation. Fortunately, Xiao Zhaohe's younger brother had a successful bone marrow formup and he was able to arrange surgical treatment in the near future. However, it is worrying that at this time, Xiaozhao's surgery fell into the embarrassing situation of "waiting for drugs" due to lack of medicine.
Sun Hui, director of the Department of Hematology at the First Affiliated Hospital of Zhengzhou University, introduced that Bai Shufei is an essential drug in bone marrow transplantation. This drug is currently very scarce, and there is only one hospital inventory left. "And according to Xiao Zhao's weight, she needs at least 12 to 13 Bai Shufei injections."
Due to the lack of necessary medicines for surgery, Xiao Zhao's surgery can only be postponed.
Not only is Zhengzhou out of stock, but patients all over the country are seeking drugs.
Yesterday, the Oriental News reporter visited Henan Provincial People's Hospital, Henan Provincial Tumor Hospital, and the Third People's Hospital of Zhengzhou City, all of whom faced an emergency situation of “whiteness is not critical and affects patients’ surgeryâ€.
Zhang Yin, director of the Department of Hematology at the Provincial People's Hospital, said that since August this year, Bai Shufei’s supply has been in short supply. Nowadays, intravenous injections of Bai Shufei have almost no inventory, and they can only be replaced with oral Baishufei during surgery. However, Bai Shufei of the oral class also began to face shortages. This has forced many patients with leukemia to be forced to search for drugs. If patients cannot find drugs, they can only be forced to choose other treatments with greater side effects. If radiotherapy is not suitable for everyone, it can only replace part of it.
It is understood that there have been illegal imitations of the Bai Shu Fei generic drugs in Japan and India. Experts recommend that patients do not purchase because generic drugs have not been tested by the state and quality and efficacy are not guaranteed. At the same time, Bai Sufei's posts are available on Weibo and forums.
This situation not only exists in Zhengzhou, in Beijing, Shanghai and other places, everywhere are looking forward to looking for patients with Bai Shufei.
Yesterday afternoon, on the Weibo, the Oriental Daily News reporter randomly entered the words "white Shu Fei" with 348 search results. Most of the contents of the patient's family are looking for Bai Shufei everywhere.
A @ baby Ankang 515's friends made a micro-Bo said that Xue Bao’s father went to the hospital today to see if there was one or two remaining Bai Shufei in the hospital. Amitabha, Buddha bless! Really he was hit by a...
@ Beijing help SOS: urgent! Who has purchased Bai Shufei's channel? Children with leukemia Xiao Tengrui will enter the transplant warehouse at the beginning of next month. Unexpectedly, the medicine Bai Shufei who is preparing to warehousing will be out of stock. The doctor will let the patient prepare for himself. This medicine is not good to buy. Who will buy Bai Shufei's channels?
Only one company in the world produces
What role does Bai Shufei play in surgery? Why frequent out of stock?
According to Zhang Yin, in recent years, the incidence of leukemia is getting higher and higher. The most effective way to treat this disease is bone marrow transplantation. Bai Shufei's role in bone marrow transplantation is that many other drugs cannot substitute. It is understood that this medicine is produced in the United States, and there is only one manufacturing enterprise in the world, and China is the only one that can be imported by Qilin Pengeng (China) Biological Pharmaceutical Co., Ltd.
In an interview with the media, Bai Tianfei, head of Bai Shufei's global pharmaceutical company, Japan Otsuka Pharmaceutical Co., Ltd., said that Bai Shufei was originally manufactured at a BVL manufacturing facility in the United States. However, due to repeated problems in the BVL production base, two years ago they had started preparations for another backup production base - DSM production base.
According to relevant regulations, the change of pharmaceutical production base requires the re-approval of the Food and Drug Administration of each country before it can enter the market.
Beitian will charge that in August this year, they had submitted their applications to the relevant regulatory authorities in China and are still under review. “Before it was approved, the original plan was to continue to provide China with Bai Shufei, which was made from the former production site BVL, but the production line at the BVL production site had recently experienced problems, which led to a global supply shortage.â€
Will build a shortage of drug reserves
Why the drug depends on imports, the relevant person in charge of the State Food and Drug Administration said that Chinese pharmaceutical companies actually have the ability to produce this drug, but because of the large investment in this drug, the profit is low, resulting in the current situation .
It is understood that in September this year, there was a shortage of protamine in cardiac surgery, and it was less than two months old. Bai Shufei, a key drug in bone marrow transplantation, was in short supply again. In this case, yesterday, the relevant person in charge of the Provincial Food and Drug Administration revealed that in recent days, the Ministry of Health and the Ministry of Industry and Information Technology issued notices on the shortage of infectious drug and first-aid-type drug supply guarantees, and required local governments to make short-term treatment of infectious diseases and emergency drugs. The supply of essential drugs is guaranteed. Therefore, the next step is to establish a system for short-term drug shortages as soon as possible.
Wu Yuewen, chief physician of Department of Hematology at the Henan Provincial Tumor Hospital, who has been paying attention to the matter, said that the latest news she received is that the Baishufei production line has resumed production and is expected to be available to various hospitals soon.
Medical Surgical Cap,Disposable Surgical Cap,Disposable Medical Surgical Cap,Disposable Nonwoven Medical Surgical Cap
Guangzhou Aikangli Medical Technology Co., Ltd. , https://www.aikanli.com